PRESS RELEASE published on 04/10/2025 at 09:03, 1 year 5 months ago EQS-Adhoc: Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 2025 - for the first time more than EUR 10.7 million revenue in one month Cantourage Group SE achieves record revenue of EUR 25.6 million in Q1 2025, surpasses EUR 10.7 million monthly revenue for the first time Record Revenue Cannabis Cantourage Group SE Q1 2025 EUR 25.6 Million
BRIEF published on 04/10/2025 at 08:57, 1 year 5 months ago Record Quarter for Cantourage Group: EUR 25.6 Million Revenue in Q1 Record Revenue Strategic Growth Market Expansion European Leadership Cannabis Demand
BRIEF published on 04/10/2025 at 08:57, 1 year 5 months ago Trimestre record pour le groupe Cantourage : 25,6 millions d'euros de chiffre d'affaires au premier trimestre Croissance Stratégique Revenus Records Leadership Européen Expansion Du Marché Demande De Cannabis
PRESS RELEASE published on 04/10/2025 at 08:52, 1 year 5 months ago Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 – for the first time more than EUR 10.7 million revenue in one month Cantourage Group SE achieves record Q1 revenue of EUR 25.6 million, surpasses EUR 10.7 million monthly revenue for the first time. Strong demand for cannabis flowers drives growth Europe Record Revenue Medical Cannabis Cantourage Group SE Market Leadership
BRIEF published on 03/11/2025 at 09:16, 1 year 6 months ago Cantourage Group SE Set for Record-Breaking Q1 Sales Cantourage Group SE Capacity Expansion Q1 Sales Medical Cannabis Market Political Uncertainty
BRIEF published on 03/11/2025 at 09:16, 1 year 6 months ago Cantourage Group SE se prépare à des ventes record au premier trimestre Groupe Cantourage SE Ventes Du Premier Trimestre Extension De Capacité Incertitude Politique Marché Du Cannabis Médical
PRESS RELEASE published on 03/11/2025 at 09:11, 1 year 6 months ago Original-Research: Cantourage Group SE (von NuWays AG): Buy Research report on Cantourage Group SE by NuWays AG reveals strong Q1 sales performance and further capacity expansion plans. Company expected to beat 2025 sales estimates NuWays AG Cantourage Group SE Capacity Expansion Q1 Sales Performance 2025 Sales Estimates
BRIEF published on 01/27/2025 at 09:06, 1 year 7 months ago Strong Growth Propels Cantourage Group SE's Positive Outlook Sales Growth Medical Cannabis Cantourage Group SE Market Expansion EBITDA Profitability
BRIEF published on 01/27/2025 at 09:06, 1 year 7 months ago Une forte croissance propulse les perspectives positives de Cantourage Group SE Croissance Des Ventes Cannabis Médical Groupe Cantourage SE Expansion Du Marché Rentabilité EBITDA
PRESS RELEASE published on 01/27/2025 at 09:01, 1 year 7 months ago Original-Research: Cantourage Group SE (von NuWays AG): Buy NuWays AG releases research on Cantourage Group SE, highlighting FY24 sales growth, EBITDA profitability, and FY25 growth expectations. Target price raised to EUR 12.50 Sales Growth NuWays AG Target Price Cantourage Group SE EBITDA Profitability
Published on 09/21/2026 at 13:30, 3 minutes ago AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
Published on 09/19/2026 at 00:55, 2 days 12 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 2 days 15 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 16 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/21/2026 at 13:25, 8 minutes ago Eurobattery Minerals’ Chairman resigns from the Board
Published on 09/21/2026 at 13:15, 18 minutes ago Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen
Published on 09/21/2026 at 13:10, 23 minutes ago vivo Ranked No. 33 in the Kantar BrandZ China Top 100 and Wins Inspirational Star of Innovation Award
Published on 09/21/2026 at 13:00, 33 minutes ago Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101
Published on 09/21/2026 at 12:33, 1 hour ago First commercial scale production of Vulcan’s proprietary VULSORB® lithium extraction material
Published on 09/21/2026 at 07:00, 6 hours 33 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/21/2026 at 07:00, 6 hours 33 minutes ago Peugeot Invest entre au capital de Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 18 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 18 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026